查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1496023

超音波诊断设备市场－2024年至2029年预测

Ultrasound Device Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 115 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

超音波诊断设备市场预计将以4.57%的复合年增长率成长，从2022年的71.45亿美元市场规模成长到2029年的97.53亿美元。

超音波技术利用声波来创造人的内臟器官和内部运动的图像。除了检查孕妇的胎儿外，它还可以帮助识别内部感染并定位不适或水肿。超音波检测技术也用于癌症检测。与其他传统技术相比，该技术是安全的。它也是一种具有成本效益的设备，并且需要更少的检测时间。

超音波诊断设备的发展涉及多种因素，包括医学领域的技术发展以及超音波技术在诊断和治疗影像中的不断扩大的应用。超音波可以应用于目标器官，而不是分析整个身体。这些因素正在增加这些技术在医院等医疗机构中的使用，预计将在未来几年推动超音波诊断设备市场的发展。

市场驱动因素：

  • 由于慢性病的增加，预计超音波设备的需求将会增加。

患有心血管疾病、肺病、癌症和糖尿病等慢性疾病的人数每天都在增加。这一增长主要是由于近年来世界上很大一部分人口生活方式的改变、不健康的饮食习惯以及对身体健康整体不太重视的态度。这主要包括千禧世代。儘管如此，许多人还是更愿意接受检查，尤其是现在他们知道有这种类型的疾病。这就需要进行全面的身体检查。

此外，超音波技术安全且具有成本效益，使其成为医疗专业人员进行筛检和治疗程序的首选。根据世界卫生组织（WHO）的报告，2020年将有近1,000万人死于癌症，其中肺癌是最常见的癌症之一。

此外，还会出现乳癌、皮肤癌、结肠癌和直肠癌等新癌症。报告也发现，90%以上的高所得国家都可以获得综合治疗。然而，低收入国家的可用性还不到 15%。 2021年6月，世界卫生组织（WHO）公布调查结果，心血管疾病占2019年全球死亡人数的32%。其中 85% 是心臟病发作和中风。为了解决这个问题，预筛选的趋势越来越明显。因此，预计未来几年对超音波技术的需求将会增加。

全球许多医疗专业人员越来越多地采用影像导引和微创疗法。超音波设备越来越多地被用作检测癌症、肾结石和许多其他临床病症的治疗技术。超音波行业的製造商预计将因这些努力和进步而看到新的商机。由于超音波检查实现的早期治疗所带来的一些积极成果，超音波技术在全世界广泛应用。

市场限制因素：

  • 超音波设备的召回和低度开发国家的需求下降可能会限制市场成长。

由于收入低，低度开发国家仍无法取得先进技术。由于这些国家的需求较低，全球超音波诊断设备的成长可能会较低。此外，最近许多超音波诊断设备的召回也是阻碍市场成长的因素之一。例如，皇家飞利浦于 2020 年召回的一款 2 类产品存在冷却功能缺陷，可能会在测试过程中伤害患者。这导致了新的超音波设备召回的威胁。

此外，超音波诊断设备需要适当的训练。预计世界许多地区缺乏训练有素的技术人员也将阻碍超音波技术在全球的推广。

欧洲地区预计将占很大份额。

欧洲先进的医院和诊断设施医疗保健系统鼓励使用超音波等医疗技术。该市场由超音波、弹性成像和 3D/4D 成像等技术创新驱动。随着人口老化和慢性病的出现，超音波影像在诊断和监测方面的价值不断增加。政府措施、研发活动和高度的医疗意识正在促进市场成长。

完善的法规环境可确保产品的安全性和有效性，增强医疗保健专业人员的信心并促进市场成长。法国、德国、英国、义大利等国家正在进行超音波研究和开发，随着超音波设备临床应用的扩大和早期商业化，欧洲超音波将占有很大的市场份额。

主要进展

  • 2022年6月－迈瑞推出Imagyn I9超音波诊断设备，这是该公司首款妇产科专用产品。该系统由迈瑞的 ZONE Sonography® Technology+ 和人工智慧增强技术提供支援，可自动识别临床场景，并在从成像优化到平面采集和量化的每个环节实现自动化。该解决方案涵盖从孕前到产后护理的各个方面，为女性健康提供全面、聪明的方法。声速校正、嵌装玻璃流、智慧脸部和智慧平面 CNS 等先进技术可实现组织侦测、视觉化和平面侦测的自动化。 Imagyn I9 Ultrasound 可透过 Mindrei 值得信赖的合作伙伴购买。
  • 2022 年 4 月 - Sonex Health 推出 UltraGuideTFR 设备，该设备使用即时超音波引导进行扳机指释放 (TFR) 手术。这种微创手术于今年稍早在市场上进行了有限的发布，它允许医生透过小切口进行 TFR，并允许患者在几天内恢復活动，而传统手术则需要几週时间。该装置由 Sonex Health 联合创始人 Darryl Burns 医学博士和杰伊史密斯 (Jay Smith) 开发，旨在透过单个切口切开肌腱鞘和 A1 滑轮。
  • 2022 年 2 月 - Butterfly Network 与 Umbra Health 合作，提高床边超音波资料的互通性。此次合作提高了 Butterfly 企业平台 Butterfly Blueprint(TM) 的扩充性，从而能够跨医院和卫生系统存取超音波资讯。 Ambra Health 利用 Butterfly Network 在整合来自主要健康系统（包括美国排名前 10 的医院中的 8 家）的影像资讯方面的经验。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章超音波诊断设备市场：依影像分类

  • 介绍
  • 腹部超音波影像
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 颈动脉和腹主动脉的超音波影像
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 产科超音波影像诊断
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 骨盆腔超音波影像
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 其他的
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第六章超音波诊断设备市场：依最终用户分类

  • 介绍
  • 医院
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 诊所
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第七章超音波诊断设备市场：按地区

  • 介绍
  • 北美洲
    • 透过影像
    • 按最终用户
    • 按国家/地区
  • 南美洲
    • 透过影像
    • 按最终用户
    • 按国家/地区
  • 欧洲
    • 透过影像
    • 按最终用户
    • 按国家/地区
  • 中东/非洲
    • 透过影像
    • 按最终用户
    • 按国家/地区
  • 亚太地区
    • 透过影像
    • 按最终用户
    • 按国家/地区

第八章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第九章 公司简介

  • Koninklijke Philips NV
  • GE Healthcare
  • CANON MEDICAL SYSTEMS CORPORATION
  • Hitachi
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthcare
  • Samsung Medison Co., Ltd.
  • Esaote
  • Hologic Inc.
  • Shimadzu Corporation
简介目录
Product Code: KSI061612165

The ultrasound device market is projected to grow at a CAGR of 4.57%, from a market size of US$7.145 billion in 2022 to US$9.753 billion in 2029.

The technology of ultrasound employs sound waves to create an image of a person's internal organs or internal bodily motions. Apart from inspecting the fetus in expectant mothers, it helps identify internal organ infections and pinpoint the location of discomfort or edema. Ultrasound techniques are also utilized for the purpose of cancer detection. This technique is safer as compared to other conventional techniques. In addition, they also consume less time in detection as well as is cost-effective devices.

Ultrasound device has various factors involved owing to the technological developments in the medical field, and expansions in applications of ultrasound techniques in diagnostic and therapeutic imaging. Rather than analyzing the entire body, ultrasound can be performed on the targeted organs. These factors are leading to an increase in the use of these technologies in healthcare facilities such as hospitals, which is expected to boost the ultrasound devices market in the years ahead.

Market Drivers:

  • Rising prevalence of chronic diseases is anticipated to increase the demand for ultrasound devices.

The population with chronic illnesses such as cardiovascular diseases, lung diseases, cancer, diabetes, and others is expanding day by day. This rise is basically due to changing ways of life, unhealthy eating habits, and overall thinking little of the body health of a major portion of the world population in recent years. This mainly includes the millennials. Still, many people prefer to be checked out, especially now that they are aware that these kinds of disorders exist. A comprehensive physical examination is necessary for this.

Moreover, due to ultrasound technology's safe and cost-effective properties, health professionals prefer using it for checkups and therapeutic procedures. As per the report by the World Health Organization, in 2020, nearly 10 million deaths were caused due to cancer, among which lung cancer is termed to be one of the most common cancers.

Furthermore, the new cases of cancer include breast cancer, skin cancer, colon, and rectum. The report also states that the availability of comprehensive treatment is in more than 90% of high-income countries. However, fewer than 15% of low-income nations have access to it. In June 2021, the World Health Organization released a study stating that cardiovascular illnesses accounted for 32% of fatalities worldwide in 2019. Of these, heart attacks and strokes accounted for 85%. To solve this issue, the inclination toward prior check-ups is growing. This expects an increase in demand for ultrasound technology in the coming years.

There is increasing adoption seen worldwide for image-guided and minimally invasive therapies by many health professionals. Ultrasound devices are transforming in use as a therapeutic technique for cancer, renal stones, and many other clinical conditions detections. Manufacturers in the ultrasound business are expected to have new opportunities as a result of these efforts and advances. Ultrasound technology has been used all across the world as a result of several positive outcomes brought about by early treatments made possible by ultrasound examinations.

Market Restraint:

  • Recalls of ultrasound devices and less demand in underdeveloped countries could limit the market growth.

Due to their low incomes, underdeveloped nations are still unable to take advantage of advanced technologies.The growth of ultrasound devices could be less globally due to lower demand in these countries. Additionally, recent recalls of many ultrasound devices are also one of the resistances to the market growth. For example, a class 2 product that was recalled by Koninklijke Philips in 2020 had a faulty cool function that could cause injury to a patient during the examination. This has created a threat to opt for a new recall of ultrasound devices.

Additionally, ultrasound equipment requires proper training since not every technician can handle the ultrasound equipment professionally without it. The lack of trained technicians in many parts of the world is also predicted to hamper the ultrasound technology expansion globally.

Europe region is predicted to hold a major share.

The sophisticated healthcare system in Europe, which consists of hospitals and diagnostic facilities, encourages the use of medical technology like ultrasonography. The market is driven by technological breakthroughs such as contrast-enhanced ultrasound, elastography, and 3D and 4D imaging. The value of ultrasonic imaging for diagnosis and monitoring is increased by the aging population and the occurrence of chronic illnesses. Government initiatives, research and development activities, and high healthcare awareness contribute to market growth.

A well-established regulatory environment ensures product safety and efficacy, instilling confidence in healthcare professionals and driving market growth. With ongoing research and developments in ultrasound, expansions in clinical applications, and early commercialization of ultrasound devices in countries such as France, Germany, the UK, and Italy, Europe is expected to hold a significant share of the ultrasound market in 2026.

Key Developments:

  • June 2022- Mindray launched the Imagyn I9 Ultrasound Machine, its first dedicated OB/GYN product. The system, powered by Mindray's ZONE Sonography(R) Technology+ and AI-enhanced technologies, uses auto-clinical scenario identification and automation at every point, from imaging optimization to plane acquisition and quantification. The solution offers a comprehensive, smart approach to women's health, covering various aspects from pre-pregnancy to post-partum care. Advanced technologies like Sound Speed Compensation, Glazing Flow, Smart Face, and Smart Planes CNS automate tissue detection, visualization, and plane detection. The Imagyn I9 Ultrasound is available through Mindray's trusted partners.
  • April 2022- Sonex Health launched its UltraGuideTFR device, which uses real-time ultrasound guidance for trigger finger release (TFR) procedures. This minimally invasive technique, used in a limited-market release earlier this year, allows physicians to perform TFR through a small incision, allowing patients to resume activities within days compared to weeks with traditional surgeries. The device, developed by Sonex Health's physician co-founders Dr. Darryl Barnes and Dr. Jay Smith, is designed to incise the tendon sheath and A1 pulley through a single incision.
  • February 2022- Butterfly Network partnered with Ambra Health to improve bedside ultrasound data interoperability. The partnership improves the scalability of Butterfly Blueprint(TM), Butterfly's enterprise platform, and access to ultrasound information across hospitals and health systems. Ambra Health leverages Butterfly Network's experience in integrating imaging information across major health systems, including eight of the top 10 hospitals in the U.S. The solution enables secure viewing and sharing of encounter-based ultrasound information, enhancing clinical decision-making.

Market Segmentation:

Ultrasound Device Market is segmented and analyzed as below:

By Imaging

  • Abdominal Ultrasound Imaging
  • Carotid & Abdominal Aorta Ultrasound Imaging
  • Obstetric Ultrasound Imaging
  • Pelvic Ultrasound Imaging
  • Others

By End-User

  • Hospitals
  • Clinics

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. ULTRASOUND DEVICE MARKET BY IMAGING

  • 5.1. Introduction
  • 5.2. Abdominal Ultrasound Imaging
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Carotid & Abdominal Aorta Ultrasound Imaging
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Obstetric Ultrasound Imaging
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Pelvic Ultrasound Imaging
    • 5.5.1. Market Opportunities and Trends
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness
  • 5.6. Others
    • 5.6.1. Market Opportunities and Trends
    • 5.6.2. Growth Prospects
    • 5.6.3. Geographic Lucrativeness

6. ULTRASOUND DEVICE MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Hospitals
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Clinics
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness

7. ULTRASOUND DEVICE MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. By Imaging
    • 7.2.2. By End-User
    • 7.2.3. By Country
      • 7.2.3.1. USA
        • 7.2.3.1.1. Market Opportunities and Trends
        • 7.2.3.1.2. Growth Prospects
      • 7.2.3.2. Canada
        • 7.2.3.2.1. Market Opportunities and Trends
        • 7.2.3.2.2. Growth Prospects
      • 7.2.3.3. Mexico
        • 7.2.3.3.1. Market Opportunities and Trends
        • 7.2.3.3.2. Growth Prospects
  • 7.3. South America
    • 7.3.1. By Imaging
    • 7.3.2. By End-User
    • 7.3.3. By Country
      • 7.3.3.1. Brazil
        • 7.3.3.1.1. Market Opportunities and Trends
        • 7.3.3.1.2. Growth Prospects
      • 7.3.3.2. Argentina
        • 7.3.3.2.1. Market Opportunities and Trends
        • 7.3.3.2.2. Growth Prospects
      • 7.3.3.3. Others
        • 7.3.3.3.1. Market Opportunities and Trends
        • 7.3.3.3.2. Growth Prospects
  • 7.4. Europe
    • 7.4.1. By Imaging
    • 7.4.2. By End-User
    • 7.4.3. By Country
      • 7.4.3.1. Germany
        • 7.4.3.1.1. Market Opportunities and Trends
        • 7.4.3.1.2. Growth Prospects
      • 7.4.3.2. France
        • 7.4.3.2.1. Market Opportunities and Trends
        • 7.4.3.2.2. Growth Prospects
      • 7.4.3.3. UK
        • 7.4.3.3.1. Market Opportunities and Trends
        • 7.4.3.3.2. Growth Prospects
      • 7.4.3.4. Others
        • 7.4.3.4.1. Market Opportunities and Trends
        • 7.4.3.4.2. Growth Prospects
  • 7.5. Middle East and Africa
    • 7.5.1. By Imaging
    • 7.5.2. By End-User
    • 7.5.3. By Country
      • 7.5.3.1. Saudi Arabia
        • 7.5.3.1.1. Market Opportunities and Trends
        • 7.5.3.1.2. Growth Prospects
      • 7.5.3.2. UAE
        • 7.5.3.2.1. Market Opportunities and Trends
        • 7.5.3.2.2. Growth Prospects
      • 7.5.3.3. Others
        • 7.5.3.3.1. Market Opportunities and Trends
        • 7.5.3.3.2. Growth Prospects
  • 7.6. Asia Pacific
    • 7.6.1. By Imaging
    • 7.6.2. By End-User
    • 7.6.3. By Country
      • 7.6.3.1. China
        • 7.6.3.1.1. Market Opportunities and Trends
        • 7.6.3.1.2. Growth Prospects
      • 7.6.3.2. India
        • 7.6.3.2.1. Market Opportunities and Trends
        • 7.6.3.2.2. Growth Prospects
      • 7.6.3.3. Japan
        • 7.6.3.3.1. Market Opportunities and Trends
        • 7.6.3.3.2. Growth Prospects
      • 7.6.3.4. South Korea
        • 7.6.3.4.1. Market Opportunities and Trends
        • 7.6.3.4.2. Growth Prospects
      • 7.6.3.5. Taiwan
        • 7.6.3.5.1. Market Opportunities and Trends
        • 7.6.3.5.2. Growth Prospects
      • 7.6.3.6. Thailand
        • 7.6.3.6.1. Market Opportunities and Trends
        • 7.6.3.6.2. Growth Prospects
      • 7.6.3.7. Indonesia
        • 7.6.3.7.1. Market Opportunities and Trends
        • 7.6.3.7.2. Growth Prospects
      • 7.6.3.8. Others
        • 7.6.3.8.1. Market Opportunities and Trends
        • 7.6.3.8.2. Growth Prospects

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Koninklijke Philips N.V.
  • 9.2. GE Healthcare
  • 9.3. CANON MEDICAL SYSTEMS CORPORATION
  • 9.4. Hitachi
  • 9.5. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 9.6. Siemens Healthcare
  • 9.7. Samsung Medison Co., Ltd.
  • 9.8. Esaote
  • 9.9. Hologic Inc.
  • 9.10. Shimadzu Corporation